New Drug Treatment Paradigms for Metabolic and Neurological Disorders

Author(s): Senthilkumar Sivanesan.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 33 , 2019


[1]
Upadhya D, Shetty AK. Extracellular vesicles as therapeutics for brain injury and disease. Curr Phar Des 2019; 25(33): 3500-5.
[2]
Kabir MT, Sufian MA, Uddin MS, et al. NMDA receptor antagonists: repositioning of memantine as a multitargeting agent for Alzheimer’s therapy. Curr Phar Des 2019; 25(33): 3506-18.
[3]
Kabir MT, Uddin MS, Begum MM, et al. Cholinesterase inhibitors for Alzheimer’s disease: multitargeting strategy based on anti-Alzheimer’s drugs repositioning. Curr Phar Des 2019; 25(33): 3519-35.
[4]
Öztürk Y, Öztürk N. Plant- and nutraceutical-based approach for the management of diabetes and its neurological complications: a narrative review. Curr Phar Des 2019; 25(33): 3536-49.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 33
Year: 2019
Page: [3499 - 3499]
Pages: 1
DOI: 10.2174/138161282533191119145548

Article Metrics

PDF: 17
HTML: 3
PRC: 1

Special-new-year-discount